A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
Conditions:   Advanced Solid Tumor;   Cutaneous T-cell Lymphoma (CTCL) Intervention:   Drug: SIM1811-03 Sponsor:   Jiangsu Simcere Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2022 Category: Research Source Type: clinical trials

BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma
Condition:   Mycosis Fungoides Intervention:   Drug: Cemiplimab Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials